Gregor Kawaletz

Gregor Kawaletz is the current Head of Business Unit Oral Solid Dosages at Recipharm. Gregor was previously the Chief Commercial Officer at Albumedix from June 2020 to September 2021. Prior to that, they were the Chief Commercial Officer at IDT Biologika GmbH from September 2014 to June 2020. Before that, they were the European Sales Director at Catalent Pharma Solutions from September 2010 to August 2014. Gregor's first role in the pharmaceutical industry was as the Key Account Director at NextPharma from January 2003 to December 2010.

They work with Jean-François Hilaire - Head of Business Unit Advanced Delivery Systems, Luc Burgard - COO, and Ulrike Lemke - Head of Transformation. Gregor Kawaletz reports to Marc Funk, CEO.